Effect of hypertonic and isotonic saline inhalation on inflammatory cells, granulocyte mediators and chemokines in induced sputum of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 792s Year: 2006
Montelukast attenuates the airway response to hypertonic saline in patients with moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Oxygen saturation decrease after both isotonic and hypertonic saline inhalation in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 698s Year: 2005
Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects Source: Eur Respir J 2004; 24: 1018-1024 Year: 2004
A small audio device may be alternative to hypertonic saline inhalation for sputum induction in patients with pulmonary tuberculosis Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008
Sequential nebulized salbutamol therapy in patients of acute bronchial asthma and its effect on serum potassium level Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge Source: Eur Respir J 2005; 26: Suppl. 49, 228s Year: 2005
Effect of inhaled mannitol on the sputum properties in asthmatics with excessive secretions Source: Eur Respir J 2006; 28: Suppl. 50, 666s Year: 2006
Dynamics of blood and sputum eosinophils in asthma patients with cold airway hyperresponsiveness during cold air provocation Source: International Congress 2019 – Airway physiology Year: 2019
Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
Inflammatory cells and granulocyte markers in hypertonic and isotonic saline-induced sputum in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 548s Year: 2003
Refractoriness following hypertonic saline challenge attenuates nocturnal asthma Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in asthma Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Exhaled breath histamine is reduced following methacholine challenge in patients with mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001
Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021
Serum potassium level in patient of bronchial asthma on sequential nebulized salbutamol therapy Source: Eur Respir J 2007; 30: Suppl. 51, 621s Year: 2007
Systemic effects of nebulized salbutamol on serum potassium, glucose and CPK-MB levels in children with acute reversible reactive airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
Sputum induction with inhaled mannitol in children Source: Eur Respir J 2015; 46: 552-554 Year: 2015
Osmolality changes in nebulizer solutions may induce bronchoconstriction in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 424s Year: 2001